EHRA Premium Access

Optimization of CRT

Event: EHRA 2021
Topic: Cardiac Resynchronisation Therapy (CRT)
Session type: Abstract Sessions
Date: 25 April 2021
Time: 16:15 - 17:10

Congress Session

6 presentations in this session

Assessing survival and re-hospitalisation following transvenous lead extraction in cardiac resynchronisation therapy devices depending on reimplantation timing: a propensity score matched analysis.

Speaker: Doctor V. Mehta (London, GB)
Thumbnail

Impact of homeometric autoregulation using a stepwise change in heart rate on dP/dtmax and time to peak dP/dt with resynchronization therapy

Speaker: Doctor H. Odland (Oslo, NO)
Thumbnail

Time delay to peak left ventricular pressure rise identifies the substrate for dyssynchronous heart failure and detects disease modification with resynchronization- an observational clinical study

Speaker: Doctor H. Odland (Oslo, NO)
Thumbnail

Electrocardiographic pattern in V1, aVL and I as predictor of events in heart failure following cardiac resincronization

Speaker: Mr J. Asensio Nogueira (Burgos, ES)
Thumbnail

Duration of the preejection phase is less preload dependent and therefore a better marker of acute response to cardiac resynchronization therapy than maximum pressure rise

Speaker: Mr M. Villegas-Martinez (Oslo, NO)
Thumbnail

Long-term mortality benefit of CRT-D vs. CRT-P upgrade procedures from conventional devices without prior ventricular arrhythmias

Speaker: Doctor W. Schwertner (Budapest, HU)
Thumbnail

6 speakers from this session

Doctor Vishal Shahil Mehta

King's College London, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor Hans Henrik Odland

Oslo University Hospital Rikshospitalet, Oslo (Norway)
1 presentation
0 follower

Doctor Hans Henrik Odland

Oslo University Hospital Rikshospitalet, Oslo (Norway)
1 presentation
0 follower

Mr Juan Asensio Nogueira

University Hospital of Burgos, Burgos (Spain)
0 follower

Mr Manuel Villegas-Martinez

Oslo University Hospital Rikshospitalet, Oslo (Norway)
0 follower

Doctor Walter Richard Schwertner

Semmelweis University Heart and Vascular Center, Budapest (Hungary)
0 follower

This platform is supported by

logo Novo Nordisk